Zumutor Biologics Inc announces FDA clearance of IND application of ZM008, a novel monoclonal antibody drug against multiple solid cancers
BOSTON and BANGALORE. India, Aug. 11, 2023 /PRNewswire/ — Zumutor Biologics Inc “Zumutor”, a Boston based biopharmaceutical company focused on
Read More